Clinic FAQ
The questions clinics and their patients ask most.
Plain answers on NAD+ and peptides — what they are, what the evidence supports, and where authorisation and supervision fit. Each product page carries its own Evidence & Regulation section with citations you can open and read.
Evidence & Regulation, per compound
Open any compound to jump straight to its citations, trial registry entries and regulator positions.
South Africa — compliance notice
SAHPRA has publicly warned about unregistered peptide products being marketed to the South African public. In general, products intended to diagnose, treat, or otherwise alter bodily functions require registration or authorisation before they may lawfully be sold. ELLIVON BIOSCIENCES publishes reference information only and directs all clinical questions to registered healthcare professionals and licensed pharmacy channels.